Advances in research of therapeutic anti-rabies virus antibodies
Jun-yuan Wang
Abstract
Jun-yuan Wang
Abstract
Rabies is fatal once clinical signs of severe rabies virus (RV) exposure are present.In order to replace rabies immune globulin from human and equine for postexposure prophylaxis of rabis,RV-neutralizing human monoclonal antibodies (mAb) have been investigated extensively.This review summarizes the therapoutic human mAb CR57 and its complementing mAb CR4098.Expresion systems of mAb are also discussed. Key words: Rabies virus; Antibodies; Monoclonal antibody CR57; Monoclonal antibody CR4098
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Rabies is fatal once clinical signs of severe rabies virus (RV) exposure are present.In order to replace rabies immune globulin from human and equine for postexposure prophylaxis of rabis,RV-neutralizing human monoclonal antibodies (mAb) have been investigated extensively.This review summarizes the therapoutic human mAb CR57 and its complementing mAb CR4098.Expresion systems of mAb are also discussed. Key words: Rabies virus; Antibodies; Monoclonal antibody CR57; Monoclonal antibody CR4098
Key concepts: Rabies, Monoclonal antibody, Rabies virus, Virology, Lyssavirus, Antibody, Virus, Rhabdoviridae